化学
细胞内
癌症干细胞
细胞毒性
癌症研究
细胞毒性T细胞
癌细胞
细胞凋亡
药物输送
癌症
细胞生物学
生物化学
生物
干细胞
体外
有机化学
遗传学
作者
Meng Liu,Shiyang Shen,Di Wen,Mengru Li,Teng Li,Xiaojie Chen,Zhen Gu,Ran Mo
出处
期刊:Nano Letters
[American Chemical Society]
日期:2018-03-16
卷期号:18 (4): 2294-2303
被引量:86
标识
DOI:10.1021/acs.nanolett.7b04976
摘要
Protein therapeutics hold increasing interest with the promise of revolutionizing the cancer treatment by virtue of a potent specific activity and reduced adverse effects. Nonetheless, the therapeutic efficacy of anticancer proteins is highly compromised by multiple successive physiological barriers to protein delivery. In addition, concurrent elimination of bulk tumor cells and highly tumorigenic cancer stem-like cells (CSCs) as a promising strategy has been evidenced to significantly improve cancer therapy. Here we show that a hierarchically assembled nanocomposite can self-adaptively transform its particulate property in response to endogenous tumor-associated signals to overcome the sequential barriers and achieve an enhanced antitumor efficacy by killing CSCs and bulk tumor cells synchronously. The nanoassemblies preferentially accumulate in tumors and dissociate under tumor microenvironmental acidity accompanied by the extracellular release of small-sized ribonuclease A (RNase A)-encapsulated nanocapsule (R-rNC) and small-molecule anti-CSC doxycycline (Doc), which exhibit increased tumor penetration and intracellular accumulation. The endocytosed R-rNC rapidly releases RNase A within both CSCs and tumor cells at intracellular reductive conditions, causing cell death by catalyzing RNA degradation, while Doc eradicates CSCs by inhibiting the mitochondrial biogenesis. The hierarchical assemblies show enhanced cytotoxicity on the CSC-enriched MDA-MB-231 mammospheres and an enhanced antitumor efficacy on the xenograft tumor mouse model.
科研通智能强力驱动
Strongly Powered by AbleSci AI